MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

cognitive health

Search medical newsFind research, conditions and clinical updates
  • Home
  • cognitive health
Moderate Caffeinated Coffee and Tea Intake Linked to 18% Lower Dementia Risk in Decades-Long Study
Posted inNeurology news Public Health

Moderate Caffeinated Coffee and Tea Intake Linked to 18% Lower Dementia Risk in Decades-Long Study

Posted by By MedXY 02/10/2026
A prospective study of over 130,000 adults reveals that consuming 2-3 cups of caffeinated coffee or 1-2 cups of tea daily significantly reduces dementia risk and cognitive decline, whereas decaffeinated coffee shows no protective effect.
Read More
How Poor Sleep Accelerates Brain Aging: The Role of Inflammation and What You Can Do
Posted inNeurology news Public Health

How Poor Sleep Accelerates Brain Aging: The Role of Inflammation and What You Can Do

Posted by By MedXY 10/08/2025
New research links poor sleep quality in middle-aged and older adults to accelerated brain aging, with inflammation playing a key role. Improving sleep may help slow cognitive decline and promote brain health.
Read More
Daily Multivitamin Use May Slow Memory Decline in Older Adults
Posted inFamily Medicine & Nutrition Medical News news Specialties

Daily Multivitamin Use May Slow Memory Decline in Older Adults

Posted by By MedXY 08/08/2025
Harvard researchers found that daily multivitamin supplementation modestly improves memory and cognition in seniors, potentially delaying cognitive aging by up to two years.
Read More
The Brain-Boosting Benefits of Tea: A Daily Habit for Cognitive Health
Posted inFamily Medicine & Nutrition news Specialties

The Brain-Boosting Benefits of Tea: A Daily Habit for Cognitive Health

Posted by By MedXY 08/06/2025
Drinking three cups of tea daily may improve brain health, reduce aging effects, and lower dementia risks according to recent studies.
Read More
The Brain-Boosting Benefits of Green Tea: Insights from Science
Posted inFamily Medicine & Nutrition Medical News news Specialties

The Brain-Boosting Benefits of Green Tea: Insights from Science

Posted by By MedXY 08/06/2025
Drinking three or more cups of green tea daily may reduce white matter lesions in the brain, promoting cognitive health and decreasing dementia risk.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Comparative Clinical Performance and Color Matching of One-Shade vs. Multi-Shade Flowable Composites in Non-Carious Cervical Lesions: An 18-Month Double-Blind Randomized Trial
  • Izalontamab Brengitecan in Heavily Pretreated HR+/HER2- Breast Cancer: Insights from the PANKU-Breast01 Phase 3 Trial in China
  • Long-Term Clinical Outcomes of Zika-Related Microcephaly: Insights from the First Five Years of Life
  • Comparative Real-World Effectiveness and Retention of Biologic DMARDs in Psoriatic Arthritis: Insights from an Emulated Multicentre Trial
  • Rising Trends and Outcomes of MASLD in Liver Transplantation: Implications for Early Detection and Management
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top